Acording to a new major study for Benign Prostatic Hyperplasia, the incidence of side effects with Dutasteride was surprisingly low. See all the side effects and their prevalance in this
An editorial by Dr. Marty Sawaya on the truth behind why Dutasteride trials were never finished despite its effectiveness, and why a new hair loss treatment with sufficient testing may
Dr. Edwin Epstein conveys his concerns with the recent type about Avodart for the off-label treatment of hair loss, in this editorial piece written from the viewpoint of the prescribing
The long awaited approval of the newest treatment expected by many to outperform Propecia, Dutasteride has been approved for availability here in the United States under the brand name Avodart.
Dr. Sawaya tells HairlossTalk why she previously spoke so enthusiastically about Dutasteride… Sawaya comments to HairlossTalk Users on Dutasteride July 13, 2001 Recently there has been some active debate in
Glaxo releases 6 mo Dutasteride Results & announces submission of NDA to the FDA. We have the results on how well Dutasteride helped Hair Loss. Dutasteride outperforms Finasteride for hair loss
Over the past few months, we have kept you up to date on the new treatment on it’s way to BPH and Hair Loss sufferers called Dutasteride. Similar to the
The Bar Harbor conference was basic hair biology oriented rather than being directed at finding treatments. There were reviews on gene expression and techniques for locating genes in disease, extensive
It has been confirmed that Glaxo has contacted a dermatological research center in Marburg, Germany regarding the completion of the final phase of trials for Dutasteride on hair loss. Kevin
